Suppr超能文献

ALKBH5 介导的 lincRNA LINC02551 的 mA 修饰增强了 DDX24 的稳定性,从而促进肝癌的生长和转移。

ALKBH5-mediated mA modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.

机构信息

Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, 430030, China.

出版信息

Cell Death Dis. 2022 Nov 5;13(11):926. doi: 10.1038/s41419-022-05386-4.

Abstract

As the most important RNA epigenetic regulation in eukaryotic cells, N6-metheyladenosine (mA) modification has been demonstrated to play significant roles in cancer progression. However, this modification in long intergenic non-coding RNAs (lincRNAs) and the corresponding functions remain elusive. Here, we showed a lincRNA LINC02551 was downregulated by AlkB Homolog 5 (ALKBH5) overexpression in a mA-dependent manner in hepatocellular carcinoma (HCC). Functionally, LINC02551 was required for the growth and metastasis of HCC. Mechanistically, LINC02551, a bona fide mA target of ALKBH5, acted as a molecular adaptor that blocked the combination between DDX24 and a E3 ligase TRIM27 to decrease the ubiquitination and subsequent degradation of DDX24, ultimately facilitating HCC growth and metastasis. Thus, ALKBH5-mediated LINC02551 mA methylation was required for HCC growth and metastasis.

摘要

作为真核细胞中最重要的 RNA 表观遗传调控之一,N6-甲基腺苷(m6A)修饰已被证明在癌症进展中发挥重要作用。然而,这种修饰在长非编码 RNA(lncRNA)中的作用及其相应功能仍不清楚。在这里,我们发现 ALKBH5 过表达以 m6A 依赖的方式下调肝癌(HCC)中的 lincRNA LINC02551。功能上,LINC02551 是 HCC 生长和转移所必需的。在机制上,LINC02551 是 ALKBH5 的真正 m6A 靶标,作为分子衔接物,阻止了 DDX24 与 E3 连接酶 TRIM27 的结合,从而减少了 DDX24 的泛素化和随后的降解,最终促进了 HCC 的生长和转移。因此,ALKBH5 介导的 LINC02551 m6A 甲基化对于 HCC 的生长和转移是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fc/9637195/f09659a4bfae/41419_2022_5386_Fig1_HTML.jpg

相似文献

2
3
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
BMC Cancer. 2021 Jun 10;21(1):686. doi: 10.1186/s12885-021-08449-5.
4
Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape.
Mol Cancer Res. 2024 Jul 2;22(7):642-655. doi: 10.1158/1541-7786.MCR-23-0720.
5
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Anticancer Res. 2020 Dec;40(12):6665-6676. doi: 10.21873/anticanres.14690.
6
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Cancer Res. 2022 Feb 15;82(4):599-614. doi: 10.1158/0008-5472.CAN-21-1628.
8
promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating expression.
Biomol Biomed. 2024 Sep 6;24(5):1216-1230. doi: 10.17305/bb.2024.10247.
9
ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.
Int J Biol Sci. 2022 Aug 1;18(13):5001-5018. doi: 10.7150/ijbs.70149. eCollection 2022.
10
Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Biochem Biophys Res Commun. 2019 Jul 5;514(4):1051-1057. doi: 10.1016/j.bbrc.2019.05.042. Epub 2019 May 13.

引用本文的文献

1
Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms.
Front Oncol. 2025 Sep 1;15:1611007. doi: 10.3389/fonc.2025.1611007. eCollection 2025.
2
ALKBH5 deficiency suppresses hepatocarcinogenesis in mice via mA-dependent STAT1 restoration.
Acta Pharmacol Sin. 2025 Aug 21. doi: 10.1038/s41401-025-01631-6.
3
The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma.
Genes Dis. 2025 Jan 20;12(5):101534. doi: 10.1016/j.gendis.2025.101534. eCollection 2025 Sep.
6
Role and mechanisms of m6A demethylases in digestive system tumors.
Am J Cancer Res. 2025 Apr 15;15(4):1436-1460. doi: 10.62347/XMAF1290. eCollection 2025.
7
Loss of DDX24 inhibits lung cancer progression by stimulating IKBKG splicing-mediated autophagy.
Theranostics. 2025 Jan 2;15(5):1879-1895. doi: 10.7150/thno.102425. eCollection 2025.
8
Role of the mA demethylase ALKBH5 in gastrointestinal tract cancer (Review).
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5463. Epub 2024 Nov 29.
9
The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications.
Front Immunol. 2024 Aug 20;15:1439485. doi: 10.3389/fimmu.2024.1439485. eCollection 2024.
10
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review.
Cancer Cell Int. 2024 Aug 24;24(1):298. doi: 10.1186/s12935-024-03480-5.

本文引用的文献

1
TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma.
Liver Int. 2023 Jan;43(1):194-207. doi: 10.1111/liv.15346. Epub 2022 Jul 7.
2
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Mol Cancer. 2022 Feb 3;21(1):34. doi: 10.1186/s12943-022-01522-y.
3
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
J Hematol Oncol. 2022 Jan 21;15(1):8. doi: 10.1186/s13045-022-01224-4.
4
HCC advances in diagnosis and prognosis: Digital and Imaging.
Liver Int. 2021 Jun;41 Suppl 1:73-77. doi: 10.1111/liv.14865.
6
A comprehensive review of m6A/m6Am RNA methyltransferase structures.
Nucleic Acids Res. 2021 Jul 21;49(13):7239-7255. doi: 10.1093/nar/gkab378.
7
Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer.
Front Oncol. 2021 Apr 13;11:630260. doi: 10.3389/fonc.2021.630260. eCollection 2021.
9
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):293-313. doi: 10.1038/s41575-020-00395-0. Epub 2021 Jan 28.
10
Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
J Exp Clin Cancer Res. 2021 Jan 23;40(1):36. doi: 10.1186/s13046-021-01838-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验